Facklam M, Schoch P, Haefely W E
Pharma Division-Preclinical Research, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
J Pharmacol Exp Ther. 1992 Jun;261(3):1106-12.
Intrinsic efficacy is the inherent ability of a ligand to induce the conformational change of its receptor that is required to transduce the event of signal recognition into a physiologically relevant response. Relating fractional receptor occupancy to fractional effect is an indirect but reliable way to assess relative intrinsic efficacy. The receptor studied was the benzodiazepine receptor (BZR), a modulatory site on the gamma-aminobutyric acidA (GABAA) receptor-chloride channel. The relationship between fractional BZR occupancy, as assessed by inhibition of [3H]flumazenil binding, and potentiation of GABA-stimulated 36Cl- influx into membrane vesicles of rat cerebral cortex was evaluated for four ligands under identical experimental conditions. Triazolam and the quinolizinone Ro 19-8022 potentiated the effect of GABA maximally by nearly 50%, diazepam by about 40% and bretazenil by approximately 20%. Potentiation of GABA-stimulated 36Cl- flux by 25% was observed at about 35% BZR occupancy for diazepam, about 45% for triazolam and about 95% for Ro 19-8022. Bretazenil did not produce 25% potentiation even at receptor saturation. Although the curves relating fractional BZR occupancy to GABA potentiation were hyperbolic and nearly superimposable for triazolam and diazepam, those for Ro 19-8022 and bretazenil displayed parabolic characteristics by inducing an effect only at very high BZR occupancy, reflecting the partial agonistic profile of the latter two compounds. The rank order of relative intrinsic efficacy determined in this study was: triazolam congruent to diazepam much greater than Ro 19-8022 greater than bretazenil.
内在效能是配体诱导其受体构象变化的固有能力,这种构象变化是将信号识别事件转化为生理相关反应所必需的。将受体占有率分数与效应分数相关联是评估相对内在效能的一种间接但可靠的方法。所研究的受体是苯二氮䓬受体(BZR),它是γ-氨基丁酸A(GABAA)受体-氯离子通道上的一个调节位点。在相同实验条件下,评估了四种配体对通过抑制[3H]氟马西尼结合评估的BZR占有率分数与GABA刺激的36Cl-流入大鼠大脑皮质膜囊泡的增强作用之间的关系。三唑仑和喹利嗪酮Ro 19-8022使GABA的作用最大增强近50%,地西泮增强约40%,布瑞扎仑增强约20%。地西泮在约35%的BZR占有率时观察到GABA刺激的36Cl-通量增强25%,三唑仑约为45%,Ro 19-8022约为95%。即使在受体饱和时,布瑞扎仑也未产生25%的增强作用。尽管三唑仑和地西泮的BZR占有率分数与GABA增强作用之间的曲线是双曲线且几乎重叠,但Ro 19-8022和布瑞扎仑的曲线通过仅在非常高的BZR占有率时诱导效应而呈现抛物线特征,反映了后两种化合物的部分激动剂特性。本研究确定的相对内在效能的排序为:三唑仑等同于地西泮远大于Ro 19-8022大于布瑞扎仑。